To clarify the functional role of RUNX1 in the GBM malignancy in vivo, we established an orthotopic GBM model in immunocompetent C57BL/6 mice by using syngeneic cell lines GL261 and CT2A. The gene discussed is RUNX1; the disease is glioblastoma.